| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5513895 | Molecular Genetics and Metabolism | 2017 | 20 Pages |
Abstract
Biomarker response after HCT is incomplete, which may reflect residual disease activity. Novel therapeutic strategies should aim for full metabolic correction to minimize clinical manifestations.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Gé-Ann Kuiper, Peter M. van Hasselt, Jaap Jan Boelens, Frits A. Wijburg, Eveline J. Langereis,